CNK
Cinemark Holdings, Inc.
CNK's fundamentals are mixed: its operating margin improved to −2.1%, while it turned 3.7% of its revenue into free cash flow. At 17x earnings, it's trading below its usual 20x. Analysts expect strong earnings growth, though they disagree widely on how much.
NBIS
Nebius Group N.V.
There isn't enough reported data to score NBIS yet.
CNK Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Healthy | |
| Weak |
CNK's revenue and cash flow are currently healthy, and its profitability is stable, but its balance sheet is weak.
NBIS Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Healthy | |
| Unavailable | |
| Healthy |
NBIS's profitability and balance sheet are currently healthy. There isn't enough data to rate its revenue and cash flow.
CNK PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 14x | $34.01 | -18% |
| Forward | 16x | $41.46 | — |
| Current | 17x | $41.46 | — |
| Fair | 20x | $49.22 | +19% |
| Expensive | 23x | $58.34 | +41% |
Historical ranges are pointers, not guarantees.
CNK has the edge over NBIS in the historical PE scenario, which offers more potential upside but is not a forecast.
NBIS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 68x | $22.45 | -83% |
| Fair | 114x | $37.67 | -71% |
| Current | 390x | $129 | — |
| Expensive | 666x | $220 | +71% |
Historical ranges are pointers, not guarantees.
NBIS's PE is 390x, but its earnings don't support one, so it isn't a reliable read right now.
CNK Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
CNK has the edge over NBIS on the outlook, with more favorable earnings expectations.
NBIS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses steady | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect NBIS's revenue to grow and its profitability to improve, with its earnings holding steady. However, they disagree widely on these estimates.
CNK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.62 | +4.9% |
| Q3 2026 | $2.50 | +134% |
| Q2 2026 | $1.86 | 0% |
| Q1 2026 | $1.30 | -16% |
| Q4 2025 | $1.04 | -50% |
| Q1 2023 | -$1.67 | +$0.75 |
| Q4 2022 | -$2.26 | +$1.29 |
| Q3 2022 | -$1.39 | +$4.23 |
| Q2 2022 | -$1.84 | +$4.38 |
CNK has the edge over NBIS in the latest year-over-year earnings comparison.
NBIS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q4 2025 | $0.33 | +$2.61 |
| Q4 2024 | -$2.28 | -456% |
| Q4 2023 | $0.64 | -36% |
| Q4 2022 | $1.00 | +$1.49 |
| Q4 2021 | -$0.49 | -156% |
| Q4 2020 | $0.87 | +89% |
| Q4 2019 | $0.46 | -73% |
| Q4 2018 | $1.71 | +434% |
NBIS has returned to profit: it earned $0.33 per share over the past year, after losing money the year before.
CNK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.1B | +24% |
| Q2 2026 | $1.1B | +16% |
| Q1 2026 | $643.1M | +19% |
| Q4 2025 | $776.3M | -4.7% |
| Q3 2025 | $857.5M | -7% |
| Q2 2025 | $940.5M | +28% |
| Q1 2025 | $540.7M | -6.6% |
| Q4 2024 | $814.3M | +27% |
CNK has the edge over NBIS in the latest year-over-year revenue comparison.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2022 | -2.5% | +27 points |
| Q1 2022 | -7.2% | +141 points |
| Q4 2021 | 6.7% | +299 points |
| Q3 2021 | -9.8% | +584 points |
| Q2 2021 | -29% | +2359 points |
| Q1 2021 | -148% | -140 points |
| Q4 2020 | -292% | -301 points |
| Q3 2020 | -594% | N/A |
CNK's operating margin was −2.5% last quarter, up 27 points from the same quarter a year ago.
NBIS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2023 | $9.7B | +53% |
| Q4 2022 | $6.3B | +46% |
| Q4 2021 | $4.3B | +63% |
| Q4 2020 | $2.6B | +24% |
| Q4 2019 | $2.1B | +37% |
| Q4 2018 | $1.5B | +36% |
| Q4 2017 | $1.1B | +24% |
| Q4 2016 | $917M | +27% |
NBIS's revenue is growing: $530M last quarter, down 80% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2025 | -115% | -112 points |
| Q4 2023 | 3.6% | -11 points |
| Q4 2022 | 2.5% | -14 points |
| Q4 2021 | -3.7% | -18 points |
| Q4 2020 | 7.4% | -9.5 points |
| Q4 2019 | 14% | -2 points |
| Q4 2018 | 16% | -14 points |
| Q4 2017 | 14% | -19 points |
NBIS's operating margin was −115% last quarter, down 123 points from the same quarter a year ago, near the bottom of its range since 2011.
CNK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2022 | -$43.1M | +$2.1M |
| Q2 2022 | $143M | +63% |
| Q1 2022 | -$137.5M | +$4.3M |
| Q4 2021 | $170.1M | +$348.9M |
| Q3 2021 | -$45.2M | -$10.8M |
| Q2 2021 | $87.5M | +$238.6M |
| Q1 2021 | -$141.8M | -$92.1M |
| Q4 2020 | -$178.8M | -475% |
CNK's free cash flow has turned positive after two years mostly in the red: $133M over the past year.
NBIS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2025 | -$3.7B | -$3.1B |
| Q4 2024 | -$562.1M | -$316.2M |
| Q4 2023 | -$245.9M | -$138.9M |
| Q4 2022 | -$107M | +$319.7M |
| Q4 2021 | -$426.7M | -539% |
| Q4 2020 | $97.3M | -66% |
| Q4 2019 | $287.9M | +$289.2M |
| Q4 2018 | -$1.3M | -101% |
NBIS has burned cash in six of the last eight quarters: −$4.6B over the past year, against −$43M the year before.
CNK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -- |
| 1 year | -6% | -7.4M shares |
| 3 years | -23% | -35.6M shares |
| 5 years | -0.7% | -874K shares |
| Available history | -0.2% | -206K shares |
CNK has 116M diluted shares, down 6% from a year ago.
NBIS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -12% | -33.3M shares |
| 1 year | -32% | -115M shares |
| 3 years | -26% | -86.9M shares |
NBIS has the edge over CNK on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2024 | $10M |
| Q4 2021 | $84.1M |
| Q4 2020 | $122.8M |
| Q4 2019 | $17.2M |
| Q4 2018 | $121.8M |
| Q4 2014 | $101.7M |
| Q4 2013 | $102.9M |
CNK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2022 | 8.9x | High |
| Q1 2022 | 13.6x | High |
| Q4 2021 | 139.1x | High |
| Q2 2020 | 12.1x | High |
| Q1 2020 | 2.8x | Moderate |
| Q4 2019 | 2.2x | Moderate |
CNK's net debt is about 8.9 years of its operating earnings (EBITDA), up from 2.8 years a year ago.
NBIS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2023 | 0.7x | Very low |
| Q4 2022 | -0.7x | Net Cash |
NBIS's net debt is less than a year of its operating earnings (EBITDA).
CNK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 69.5 | Neutral |
| Stochastic | 82.2 | Overbought |
CNK's weekly RSI is 69 (neutral) and its Stochastic is 82 (overbought).
NBIS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.0 | Neutral |
| Stochastic | 8.3 | Oversold |
NBIS's weekly RSI is 38 (neutral) and its Stochastic is 8 (oversold).
CNK PE vs Communication Services Sector
| Metric | CNK | Sector median | Relative |
|---|---|---|---|
| PE | 17x | 16x | 0.5% above |
| PE % | 36 | 26 | 10 pts above |
CNK has the edge over NBIS on valuation relative to its sector.
NBIS PE vs Communication Services Sector
| Metric | NBIS | Sector median | Relative |
|---|---|---|---|
| PE | 390x | 16x | 2,264% above |
| PE % | 62 | 24 | 38 pts above |
NBIS is trading at 390x earnings, a 2264% premium to the Communication Services sector's median of 16x, though its earnings don't support one.
CNK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $38.5 | 7.7% above |
| 20 week MA | $36.0 | 15% above |
| 50 week MA | $30.6 | 36% above |
| 100 week MA | $29.6 | 40% above |
| 200 week MA | $24.3 | 71% above |
CNK has stronger trend alignment. CNK is above 5 of 5 weekly averages versus NBIS above 1 of 4.
NBIS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $179.7 | 28% below |
| 20 week MA | $199.9 | 36% below |
| 50 week MA | $163.5 | 21% below |
| 100 week MA | $110.0 | 17% above |
NBIS has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 17% above its 100-week average.
CNK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $34.0 | $16.5 | -51% |
| 2021 | $16.5 | $17.4 | +5.6% |
| 2022 | $17.4 | $8.64 | -50% |
| 2023 | $8.64 | $14.1 | +63% |
| 2024 | $14.1 | $31.0 | +120% |
| 2025 | $31.0 | $22.9 | -26% |
| 2026 YTD | $22.9 | $41.5 | +81% |
CNK has the edge over NBIS on returns for 2026, with the stronger performance.
NBIS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2024 | $19.6 | $27.3 | +40% |
| 2025 | $27.3 | $87.6 | +221% |
| 2026 YTD | $87.6 | $128.6 | +47% |
NBIS has finished every year since 2024 higher, and it's up 47% so far in 2026.